Cargando…

Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis

Cirrhosis is frequently the final stage of disease preceding the development of hepatocellular carcinoma (HCC) and is one of the risk factors for HCC. Preventive surveillance for early HCC in patients with cirrhosis is advantageous for achieving early HCC prevention and diagnosis, thereby enhancing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yaqun, Li, Jianhua, He, Tianye, Song, Yun, Wu, Jian, Wang, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778294/ https://www.ncbi.nlm.nih.gov/pubmed/36553600 http://dx.doi.org/10.3390/genes13122331

Ejemplares similares

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis
por: Xie, Shucai, et al.
Publicado: (2019)

Nucleoside analogs treatment delay the onset of hepatocellular carcinoma in patients with HBV-related cirrhosis
por: Bi, Jingfeng, et al.
Publicado: (2017)

The HBV Specially-Related Long Noncoding RNA HBV-SRL Involved in the Pathogenesis of Hepatocellular Carcinoma
por: Zhang, Cunzhen, et al.
Publicado: (2022)

Prognostic value of albumin‐related ratios in HBV‐associated decompensated cirrhosis
por: Zhang, Tan, et al.
Publicado: (2022)

Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma
por: Jiang, Chen Hao, et al.
Publicado: (2020)

Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma
por: Yao, Qinwei, et al.
Publicado: (2017)

Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy
por: Zhu, Dong-Mei, et al.
Publicado: (2020)

Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy
por: Nam, Joon Yeul, et al.
Publicado: (2020)

Serum potassium levels and prognosis in HBV‐associated decompensated cirrhosis
por: Huang, JianJiang, et al.
Publicado: (2021)

Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma
por: Liao, Rui, et al.
Publicado: (2013)

FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
por: Lu, Xiao-Jie, et al.
Publicado: (2020)

Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis
por: Thompson Coon, J, et al.
Publicado: (2008)

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
por: Yoon, Jun Sik, et al.
Publicado: (2020)

Immunologic Characterization of Posthepatitis Cirrhosis Caused by HBV and HCV Infection
por: Li, Wan-Yu, et al.
Publicado: (2010)

Screening for Lipid-Metabolism-Related Genes and Identifying the Diagnostic Potential of ANGPTL6 for HBV-Related Early-Stage Hepatocellular Carcinoma
por: Zuo, Duo, et al.
Publicado: (2022)

Screening of the Key Genes for the Progression of Liver Cirrhosis to Hepatocellular Carcinoma Based on Bioinformatics
por: Chen, Yuanbin, et al.
Publicado: (2022)

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2019)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
por: Lee, Junggyu, et al.
Publicado: (2015)

Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
por: Essa, Abdallah, et al.
Publicado: (2023)

Surveillance for Hepatocellular Carcinoma after Autologous Stem Cell Transplantation in Cirrhosis
por: Mohamadnejad, Mehdi, et al.
Publicado: (2012)

Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe
por: Chin'ombe, Nyasha, et al.
Publicado: (2009)

Molecular mechanism of CK19 involved in the regulation of postoperative recurrence of HBV-associated primary hepatocellular carcinoma in Guangxi
por: Su, Hao, et al.
Publicado: (2021)

Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2020)

Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging
por: Wei, Yi, et al.
Publicado: (2017)

The Levels of Ghrelin, Leptin, TNF-α, and IL-6 in Liver Cirrhosis and Hepatocellular Carcinoma due to HBV and HDV Infection
por: Ataseven, Huseyin, et al.
Publicado: (2006)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma
por: Tat Trung, Ngo, et al.
Publicado: (2018)

Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma
por: Wang, Li, et al.
Publicado: (2016)

Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study
por: Lapointe-Shaw, Lauren, et al.
Publicado: (2018)

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance
por: Ganne-Carrié, Nathalie, et al.
Publicado: (2021)

Clinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis
por: Liu, Dong, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis
por: Zhang, Honggang, et al.
Publicado: (2016)

Machine Learning-based Prediction of HBV-related Hepatocellular Carcinoma and Detection of Key Candidate Biomarkers
por: KUCUKAKCALI, Zeynep, et al.
Publicado: (2022)

A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors
por: Li, Yaqun, et al.
Publicado: (2022)

Bioinformatic identification of key genes and pathways that may be involved in the pathogenesis of HBV-associated acute liver failure
por: Yang, Yalan, et al.
Publicado: (2018)

Nine hub genes related to the prognosis of HBV-positive hepatocellular carcinoma identified by protein interaction analysis
por: Xie, Wenhui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6bdvgpe4iuvdihfrg3eg4bd35o